Most respiratory and asthma related deaths still occur in low to mid income countries. COPD is currently the fourth leading cause of death, expected to become the third by 2030. In Asia Pacific and India, asthma and COPD are particularly relevant as risk factors such as smoking, biomass fuels, pollution, and tuberculosis (TB) are higher than other regions.

Croissance Clinical Research (CCR) has gained notable experience in conducting respiratory studies, ranging from protocol writing to conducting end to end studies. Nearly three fourth of our experience has been in the two most prevalent airway diseases – Asthma and chronic obstructive pulmonary disease (COPD). Along with having conducted 4 respiratory device studies. In the past three years, we have been part of more than 14 respiratory studies involving nearly 2500 patients at 120 plus sites.

EXPERIENCE
INDICATIONS

  • Asthma
  • Allergic rhinitis
  • Pulmonary hypertension
  • Pneumonia
  • COPD
  • Cystic Fibrosis
  • Trials: 14
  • Sites: 120
  • Subjects: 2,500
  • Phases: III, IV, Observational
  • Services: Clinical Operations, Data management,  Biostatistics and Medical Writing

CCR’s Investigator database comprises more than 300 investigators across India with expertise in the respiratory. Also, our experienced team of Data Management, Clinical Operations, Project Management and Medical Affairs professionals are well-versed in managing and monitoring the procedures associated with objectives and end points in respiratory protocols.

Our deep respiratory expertise and focused operational staff enables us to fill and complete clinical trials in the best possible time, we maintain a network of research associates, investigators and trial sites with specific experience in pulmonary indications enabling us to provide rapid feasibility and help you meet your respiratory trial goals.

Although reducing time to market is important in all studies, vaccine studies are often a high-stakes race against the clock. Deadlines are often determined by seasonality or the spread of disease. Furthermore, it is difficult to compress timelines in the stages of vaccine development and production. Croissance Clinical Research has optimized many of the time-critical operational processes in clinical trials of vaccines to make your vaccine reach market at the earliest. We understand the unique challenges associated with vaccine development and take your objectives to heart.

Croissance Clinical Research (CCR) has gained notable experience in conducting vaccine studies, ranging from protocol writing to conducting end to end studies. In the past three years, we have been part of more than 11 vaccine studies involving nearly 4500 patients at 80 plus sites.

CCR has experience with a broad range of vaccines, including the following:

EXPERIENCE
INDICATIONS

  • Rota Virus
  • TCV
  • TCV Measles
  • Japanese Encephalitis
  • Pentavalent (DTwP-Hb-Hib)
  • Influenza
  • Trials: 11
  • Sites: 120
  • Subjects: 4,500
  • Phases: II-b, III, IV
  • Services: Clinical Operations, Data management,  Biostatistics and Medical Writing

CCR’s Investigator database comprises more than 200 investigators across India with expertise in the Vaccine studies. Also, our experienced team of Data Management, Clinical Operations, Project Management and Medical Affairs professionals are well-versed in managing and monitoring the procedures associated with objectives and end points in Vaccine protocols.

It is estimated that 347 million people worldwide have diabetes and diabetes deaths will increase by two thirds globally between 2008 and 2030. Endocrinology challenges affect many conditions, many diseases, and many patients. Treatment is often complex and time consuming, and there is a growing need for medical research in this arena.

Our team is experienced in providing resources needed to navigate the challenges to products outcomes. We have supported many studies in Endocrinology over the years since inception. Our therapeutic expertise is just one more reason why Croissance is a good partner for your trials in Diabetology.

Our expertise includes, but is not limited to below mentioned therapeutic areas where we have supported our clients.

EXPERIENCE
INDICATIONS

  • Diabetes mellitus
  • Gestational Diabetes Mellitus
  • Diabetic nephropathy
  • Diabetic neuropathy
  • Trials: 5
  • Sites: 200
  • Subjects: 10,500
  • Phases: IV, Observational, IIT
  • Services: Clinical Operations, Data management,  Biostatistics and Medical Writing

Despite improvements in therapeutic options rheumatic diseases remain serious and life-threatening diseases. Patients continue to have active disease and adequate treatment of some of rheumatic diseases still remains a challenge. Not all products are effective in patients, reinforcing the need for new drugs.

At Croissance we are ready to meet our clients’ dynamic study requirements. We understand that achieving recruitment goals is not enough; the quality of the participating sites is of the utmost importance. Our clinical team selects sites with dedicated, experienced investigators and the appropriate patient population which is usually not a small task for a study in rheumatology. Croissance large network of experienced investigators provides timely recruitment for rheumatology studies.

Our trials are very well managed and monitored by Croissance study team with good experience in rheumatology trials. We have a team of core professionals who can support programs in rheumatology with knowledge gained from past programs with similar populations, therapies and investigative sites.

Our team has clinical trial experience in a variety of indications including:

EXPERIENCE
INDICATIONS

  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Gout
  • Trials: 3
  • Sites: 50
  • Subjects: 500
  • Phases: III, IV, Observational
  • Services: Site Management, Data management,  Biostatistics and Medical Writing

The skin is the largest and most visible organ of the body. Unfortunately, at one time or another, nearly everyone has some type of skin disease – infants, children, teenagers, adults and the elderly. One in six (15%) of all visits to the family doctor involves a skin problem. Common skin diseases include fungal infections, Dermatitis, Hand dermatitis, atopic eczema, and herpes.

Our clinical teams are well versed in all phases of the clinical study process. From study start-up and IRB/IEC approval to patient recruitment and study conduct. With our therapeutic and clinical expertise, we focus together on your needs, and strategically customized services for each project allowing you to make decisions quickly and move your development programs forward at an express pace. The enrolment strategy developed by Croissance usually results in recruitment which exceeds the projected recruitment rate.

EXPERIENCE
INDICATIONS

  • Herpes Zoster
  • Staphylococcus Aureus
  • Bacterial Skin Infections
  • Wrinkles
  • Trials: 4
  • Sites: 65
  • Subjects: 700
  • Phases: IV, Observational
  • Services: Site Management, Data management,  Biostatistics and Medical Writing

Today, millions of people are living with cancer or have had cancer. There are many kinds of cancer, but they all start because of out-of-control growth of abnormal cells. There is a tremendous amount of research being conducted on all areas of oncology, ranging from cancer cell biology to chemotherapy treatment regimens and optimal palliative care and pain relief. This makes oncology a continuously changing and developing field.

Our team is experienced in Conducting Oncology studies and have handled Non-Hodgkin’s Lymphoma and Breast cancer studies. Apart from these the team is familiar with many of the key endpoints in oncology studies.

EXPERIENCE
INDICATIONS

  • Non-Hodgkin’s Lymphoma
  • Breast cancer
  • Trials: 2
  • Sites: 5
  • Subjects: 40
  • Phases: III
  • Services: Site Management, Data management and Biostatistics

We all depend on our vision in more ways that we may realize. Without healthy vision, our ability to work, play, drive or even recognize a face can be drastically affected. Many factors can affect our eyesight, including other health problems such as high blood pressure or diabetes. Having a family member with eye disease can make you more prone to having that condition as well. Sight-stealing eye disease can appear at any time. Very often they are unnoticeable at first and are difficult to detect. Early detection and treatment can protect your vision.

By concentrating the attention of experienced medical and scientific professionals in Ophthalmology, we have gained a depth of knowledge in this area. Our therapeutically focused team includes experienced project managers, clinical research associates and medical writers.

Over team has substantial experience in handling multiple studies in Ophthalmology and has worked on indications in area including

EXPERIENCE
INDICATIONS

  • Open Angle glaucoma
  • Ocular Hypertension  
  • Age-related macular degeneration (AMD)
  • Diabetic macular edema
  • Trials: 4
  • Sites: 45
  • Subjects: 868
  • Phases: III, IV, Observational
  • Services: Site Management, Data management, Biostatistics and Medical Writing

With the changing lifestyle, heart diseases have become a global health problem with no geographic, gender & socio-economic boundaries. This is true in all areas of the world except Africa. Together they resulted in 17.3 million deaths (31.5%) in 2013 up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults.

Our Cardiology team is made up of experienced project managers & CRAs with access to leading cardiology investigators & patient pool. We have conducted multiple cardiology trials that involves participation of more than 20 sites and 600 subjects. Cardiovascular research often requires high patient pool which may lead to competition for investigators and patients. We are unique in the industry in terms of its many long-term relationships with key Investigators and opinion leaders that specialize in cardiovascular trials.

Our staff has the experience to develop innovative strategies and to deliver quality services for your cardiovascular development program.

Our experience includes:

  • Coronary artery disease
  • Heart failure
  • Hypercholesterolemia
  • Acute myocardial infraction